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Comparison of Effectiveness of Different Antiplatelet Doses of Aspirin in Patients
with Acute Coronary Syndrome
Haci Ali Kürklü, Çagdas¸ Özdöl, Türkan Seda Tan Kürklü, Aydan Ongun, Çetin Erol
Ankara University Medical Faculty, Ankara
Aım: Aspirin is an inhibitor of platelet function and is one of the cornerstones of acute
coronary syndrome (ACS) treatment. However, the ideal dose and usage of aspirin in
patients with ACS is not clear. The aim of this study is to investigate the antiplatelet
effects of different aspirin doses and application ways in patients with ACS.
Method: This study included 30 patients that were admitted to Cardiology Clinic of
Ankara University Faculty of Medicine with a diagnosis of acute coronary syndrome.
The patients included in the study were divided into three groups based on the dose of
aspirin utilization (1x100 mg, 1x300 mg, and 3x100 mg). On 3rd day of acute
coronary syndrome, thrombocyte aggregation levels, which were assesed by Ver-
ifyNow aspirin test, were compared at 2 hours (early) and 24 hours (late) after initial
aspirin.
Results: Ten of the patients (33%) were women and 20 were men (67%) and mean
age was 61.211.5 years. According to demographic and laboratory characteristics,
no statistical difference was determined between the groups. Antiplatelet effect of
aspirin at 2nd hour were as follows respectively; 402.429.3 ARU in aspirin 300mg
per day group, 440.436.7 ARU in 100mg 3 times a day group and 418.241 ARU
in aspirin 100 mg per day group (p¼0.04). All groups’ ARU values were increased at
24th hour compared with ﬁrst 2nd hour measurements but this increase was minimum
in 3x100 mg aspirin group. There were no difference in ARU values at 24th hour
measurement between groups. No aspirin resistance observed in any of the patients.
Conclusıon: Antiplatelet effect of both 100 mg and 300 mg aspirin doses decreased
during the day but their efﬁcacy still continued and no difference was detected
between the doses. Despite the theoretical advantages of the use of aspirin in divided
doses, our study did not support this.
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2nd hour
VerifyNow
ARU
402,429,3 440,436,7 418,241 0,04
24th hour
VerifyNow
ARU
432,329 453,945,7 452,445,2 0,45 Table 1
Variable Group 1(n¼26) Group 2 (n¼ 79) p
Age (years) 54.0  10.2 61.3  9.4 <0.01
Male gender (%) 7 (26.9) 49 (62.0) <0.01
BMI (kg/m2) 29.9  4.0 29.5  5.2 0.73
Waist circumference (cm) 99.5  9.5 104.7  9.9 0.11
Current smoker (%) 6 (23.1) 21 (26.6) 0.72
Hypertension (%) 11 (42.3) 32 (40.5) 0.91
Diabetes mellitus (%) 5 (19.2) 20 (25.3) 0.57
Dyslipidemia (%) 4 (15.4) 15 (19.0) 0.74
WBC (x103/mL) 7.2  1.4 7.5  1.9 0.42
Neutrophil count (x103/mL) 3.9  1.0 4.4  1.2 0.11
Neutrophil/Lymphocyte Ratio 1.7  0.4 2.0  0.8 0.04
Vessel score 0 0.8  1.1 (0–3) <0.01
Gensini score 0 44.2  58.5 (1–204) <0.01
SYNTAX score 0 11.7  6.6 (2–26) <0.01
NGAL (pg/mL) 6.0  1.3 11.9  3.3 <0.01
Patient demographics and clinical characteristics.PP-287
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Implication of Serum Neutrophil Gelatinase-Associated Lipocalin Levels in
Patients Who Underwent First-time Diagnostic Coronary Angiography
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1Bezmi Âlem Foundation University, Faculty of Medicine, Department of Cardiology,
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Purpose: Atherosclerosis is a chronic inﬂammatory process and systemic inﬂamma-
tion plays key role in each step from endothelial dysfunction, formation of athero-
matous plaques, to clinical presentation as symptomatic coronary artery disease
(CAD) due to plaque rupture and formation of occlusive thrombus. Neutrophil
gelatinase-associated lipocalin (NGAL) is a protein secreted by activated neutrophils
which recently demonstrated as a diagnostic marker of CAD. The aim of this study is
to investigate clinical relevance of circulating NGAL levels in patents who underwent
coronary angiography with suspected CAD.
Methods: One hundred and ﬁve consecutive patients (49 females, 56 males; mean age
59.7 years) who underwent ﬁrst-time diagnostic coronary angiography from March
2013 to June 2013 were included in this study. Peripheral blood samples were taken
from antecubital vein for determination of hemogram and serum NGAL concentra-
tions before coronary angiography. Patients with impaired renal function and elevated
white blood cell counts were excluded. The severity and extent of CAD was evaluated
by calculation of vessel and Gensini scores. Also, SYNTAX score was calculated in
patients with 50% stenosis. Results were reported as mean  standard deviation and
percentages. Continuous variables were analyzed using the Student's t-test. A value of
p < 0.05 was considered statistically signiﬁcant.C196 JACC VoResults: Demographic and clinical characteristics of the patients were listed in Table
1. Patients with CAD (group 2) were signiﬁcantly older compared to patients without
CAD (group 1) and the number of male patients were signiﬁcantly higher in group 2
(p<0.05). Although white blood cell and polymorphonuclear neutrophil counts were
not different in both groups, neutrophil to lymphocyte ratio (NLR) was signiﬁcantly
elevated in group 2 (p¼0.04). Serum NGAL levels in patients with CAD were
signiﬁcantly higher than those in patients without CAD (11.9  3.3 vs 6.0  1.3 pg/
mL; p<0.01). The NGAL levels were correlated with NLR, the number of diseased
vessels and Gensini score but not with the SYNTAX score (Figure 1). The diagnostic
value for serum NGAL in discriminating patients without CAD from those with CAD
was high (AUC¼0.975). If we used as cutoff for serum NGAL 7.5 pg/mL, we could
predict presence of CAD with sensitivity and speciﬁty, 92.3% and 97.5%,
respectively.
Conclusıons: We demonstrated that serum levels of NGAL as a biomarker of
neutrophil activation are higher in patients with CAD than in patients without CAD. It
could be used to discriminate patients with CAD before diagnostic coronary angi-
ography. Also, it was positively and signiﬁcantly correlated with severity and extent of
CAD.PP-289
Is Metabolic Syndrome Related with Coronary Artery Disease Severity and
Complexity: An Observational Study About IDF And AHA/NHLBI Metabolic
Syndrome Deﬁnitions?
Ahmet Çagrı Aykan, _Ilker Gül, Ezgi Kalaycıoglu, Tayyar Gökdeniz, Engin Hatem,
Ümit Mentes¸e
Ahi Evren Chest Cardiovascular Surgery Education and Research Hospital, Trabzon
Background: The aim of the present study was to assess the association between
metabolic syndrome (MS) and coronary artery disease (CAD) complexity assessed by
SYNTAX score (SS) and severity in non-diabetic patients with stable CAD whom
underwent coronary angiography and to evaluate whether the MS deﬁned by different
deﬁnitions including International Diabetes Federation (IDF) and (American Heartl 62/18/Suppl C j October 26–29, 2013 j TSC Abstracts/POSTERS
